Connect Sign In
LabMind podcasts
“The Hidden Costs of Outsourcing Clinical Laboratory Functions” highlights critical factors that healthcare leaders must weigh when making outsourcing decisions. |
January 27, 2025 |
New ARUP White Paper Tackles the Hidden Costs of Outsourcing Clinical Laboratories A new ARUP white paper highlights the potential indirect costs of outsourcing laboratories and suggests ways for clinical laboratories to demonstrate their value to the health system. |
ARUP Consult® has timely resources on influenza viruses, COVID-19, and RSV. |
January 13, 2025 |
ARUP Consult Provides Resources for Clinicians Diagnosing Viral Respiratory Infections ARUP Consult offers expert guidance on laboratory testing for influenza, RSV, and COVID-19, helping clinicians order the right tests at the right time. |
Laboratories that utilize laboratory-developed tests (LDTs) will need to begin complying with some quality management system requirements by May 6, 2025. |
January 8, 2025 | ARUP Healthcare Advisory Services can help labs prepare for the quality management system requirements in the FDA’s final rule on laboratory-developed tests, despite the rule’s uncertain future. |
ARUP’s Human Resources team filled the International Rescue Committee’s box truck with donations collected during the holidays from employees. |
January 6, 2025 |
ARUP and Its Employees Give Two Truckloads of Donations to Refugee Families Resettling in Utah ARUP supported 15 families resettling in Utah through the International Rescue Committee’s Light One Candle initiative with donations that included toys, toiletries, and TVs. |
ARUP’s new assay, Influenza A (H5) Virus by Qualitative NAAT (ARUP test number 3018970), will expand the national capacity to detect the current outbreak of highly pathogenic avian influenza A (H5N1). |
January 3, 2025 | ARUP has launched a new assay for the detection and subtyping of influenza A (H5) virus, which will expand the national capacity to detect the current outbreak of highly pathogenic avian influenza A (H5N1). |
Benjamin Bradley, MD, PhD, medical director of the ARUP Institute for Research and Innovation in Infectious Disease Genomic Technologies, High Consequence Pathogen Response, Virology, and Molecular Infectious Diseases, participated in a media briefing on avian influenza. |
December 20, 2024 |
ARUP Medical Director: We Are Monitoring H5N1 (Bird Flu) and Have the Capacity To Detect It Benjamin Bradley, MD, PhD, compared the H5N1 outbreak to COVID-19, highlighting the preparedness of labs and the CDC’s proactive approach during a media briefing. |
ARUP Institute for Research and Innovation in Diagnostic and Precision Medicine™ We accelerate the development and adoption of cutting-edge diagnostic and prognostic technologies advancing patient care through groundbreaking science and engineering. The Sherrie Perkins Research and Innovation Collaboration Grant The Sherrie Perkins Research and Innovation Collaboration Grant funds cutting-edge research in laboratory medicine.
ARUP Newsroom
Live Chat